BioSig Technologies, Inc. (BSGM)’in fiyatı nedir?

BioSig Technologies, Inc. (BSGM)’in fiyatı $5.52’dir

BioSig Technologies, Inc. (BSGM)’in piyasa değeri nedir?

BioSig Technologies, Inc. (BSGM)’in piyasa değeri $775.10M’dir.

BioSig Technologies, Inc. (BSGM) Tedavüldeki Hisseler

BioSig Technologies, Inc., along with its subsidiaries, operates as a medical technology enterprise. Its core innovation is the PURE EP (precise uninterrupted real-time evaluation of electrograms electrophysiology) system. This proprietary signal processing platform, merging specialized hardware and software, tackles well-known difficulties in electrophysiological signal acquisition, empowering electrophysiologists to instantaneously view and analyze vital cardiac signals. The system further enhances the collection of intracardiac signals and diagnostic data crucial for atrial fibrillation procedures. Moreover, it is specifically engineered to overcome persistent obstacles that traditionally slow down and complicate cardiac catheter ablation. BioSig also holds a research agreement with the University of Minnesota, targeting the development of new treatments for sympathetic nervous system disorders. Additionally, it has a strategic partnership with the Mayo Foundation for Medical Education and Research, focused on creating an advanced AI and machine learning software solution tailored for its PURE EP platforms. Established in 2009, BioSig Technologies, Inc. is headquartered in Westport, Connecticut.

Yıl	Tedavüldeki Hisse Sayısı	Değiştir
2026 (TTM)	333.52M	137.52%
2024	140.42M	91.00%
2023	73.52M	70.68%
2022	43.07M	28.53%
2021	33.51M	20.09%
2020	27.91M	34.85%
2019	20.69M	42.68%
2018	14.50M	41.92%
2017	10.22M	31.09%
2016	7.80M	38.20%
2015	5.64M	46.14%
2014	3.86M	17.86%
2013	3.28M	-89.94%
2012	32.57M	-0.03%
2011	32.58M	0.00%

Yıl

Tedavüldeki Hisse Sayısı

Değiştir

2026 (TTM)

333.52M

137.52%

2024

140.42M

91.00%

2023

73.52M

70.68%

2022

43.07M

28.53%

2021

33.51M

20.09%

2020

27.91M

34.85%

2019

20.69M

42.68%

2018

14.50M

41.92%

2017

10.22M

31.09%

2016

7.80M

38.20%

2015

5.64M

46.14%

2014

3.86M

17.86%

2013

3.28M

-89.94%

2012

32.57M

-0.03%

2011

32.58M

0.00%

Şirket	Tedavüldeki Hisse Sayısı	Fark	Ülke
Abbott Laboratories ABT.US	1.74B	422.62%	US
Stryker Corporation SYK.US	383.50M	14.99%	US
Medtronic plc MDT.US	1.28B	284.41%	IE
Boston Scientific Corporation BSX.US	1.48B	343.03%	US
Siemens Healthineers AG SHL.DE	-	-	DE

Şirket

Tedavüldeki Hisse Sayısı

Fark

Ülke